CalciMedica regains Nasdaq listing compliance
CalciMedica announces it has regained compliance with Nasdaq’s $1.00 minimum bid price rule and reports no outstanding Nasdaq deficiency notices.
Rhea-AI Filing Summary
CalciMedica, Inc. (CALC) reports that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price requirement. Nasdaq’s Listing Qualifications Department notified the company on September 15, 2026 that, for 10 consecutive business days from August 31 to September 14, 2026, the closing bid price of its common stock was at or above $1.00 per share, satisfying the Minimum Bid Price Requirement. This cures the deficiency previously noted in a March 16, 2026 notice, which had given the company 180 calendar days, until September 14, 2026, to regain compliance. As of this report, CalciMedica states that it has no outstanding deficiency notices from Nasdaq.
Positive
- CalciMedica has regained compliance with Nasdaq Listing Rule 5550(a)(2) after maintaining a closing bid price of at least $1.00 for 10 consecutive business days, and reports no outstanding Nasdaq deficiency notices.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Minimum bid price threshold: $1.00 per share
Prior non-compliance period trigger: 30 consecutive business days
Compliance confirmation period: 10 consecutive business days
+2 more
5 metrics
Minimum bid price threshold
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement
Prior non-compliance period trigger
30 consecutive business days
Period during which CALC’s bid price was below $1.00 before the March 16, 2026 notice
Compliance confirmation period
10 consecutive business days
Days from August 31, 2026 to September 14, 2026 with closing bid at or above $1.00
Compliance deadline window
180 calendar days
Time from March 16, 2026 notice until September 14, 2026 to regain compliance
Notice date of regained compliance
September 15, 2026
Date Nasdaq staff notified CALC that it met the Minimum Bid Price Requirement
Key Terms
Nasdaq Listing Rule 5550(a)(2), Minimum Bid Price Requirement, Listing Qualifications Department
3 terms
Nasdaq Listing Rule 5550(a)(2) regulatory
"the Company was not in compliance with Nasdaq’s Listing Rule 5550(a)(2)"
Minimum Bid Price Requirement financial
"below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”)"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Listing Qualifications Department regulatory
"received notice from the Nasdaq Listing Qualifications Department"
A listing qualifications department is the part of a stock exchange that checks whether a company meets the exchange’s rules for being listed and staying listed. Think of it as a gatekeeper or building inspector: it reviews financial statements, disclosure practices and corporate governance, flags problems and can require fixes or remove a company’s shares. Investors care because its decisions affect whether a stock remains tradable and how much trust to place in a company’s reporting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq compliance update did CalciMedica (CALC) report on September 15, 2026?
CalciMedica reported that Nasdaq notified the company on September 15, 2026 it had regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock closed at or above $1.00 per share for 10 consecutive business days.
What is the Minimum Bid Price Requirement mentioned for CALC?
The Minimum Bid Price Requirement is Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for a company’s common stock over a defined compliance period.
When did CalciMedica (CALC) receive its original Nasdaq deficiency notice?
CalciMedica received the original Nasdaq deficiency notice on March 16, 2026, stating that its common stock had traded below $1.00 per share for 30 consecutive business days, triggering non-compliance with the Minimum Bid Price Requirement.
Does CalciMedica (CALC) currently have any Nasdaq deficiency notices outstanding?
No. CalciMedica states that as of the date of this report, it has no outstanding deficiency notices from Nasdaq following the determination that it regained compliance with the Minimum Bid Price Requirement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
